250+ investors that invest in your industry and stage
Marketplace
Gaming
Community
Proptech
Biotech
Impact
Health Care
FinTech
Energy
Google
Artificial intelligence
Consumer
Climate
Hardware
EdTech
Sustainability
Venture Capital
Real Estate
Digital Media
Finance
Retail
Music
Web3
Video Games
Android
Publishing
Beauty
Franchise
Education
Construction
B2B
Payments
Enterprise Software
Organic Food
Sports
Infrastructure
Manufacturing
Food and Beverage
Financial Services
Photography
Email
Clean Energy
Internet
Big Data
Biotechnology
Local
Cannabis
Social Network
Fitness
Travel
Social Media
Recruiting
Platforms
Wellness
Mobile Advertising
Medical
Hospitality
Art
Automotive
Legal
Crowdfunding
Social
Medical Device
Mobile
Wine And Spirits
eSports
CleanTech
Mobile Apps
InsurTech
Transportation
Enterprise
LGBT
Fashion
Oil and Gas
Theatre
Film
Life Science
SaaS
Non Profit
Renewable Energy
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
United Kingdom
United States
Germany
India
Australia
Canada
New Zealand
South Korea
Ireland
Saudi Arabia
Brazil
Armenia
Qatar
Asia
Sri Lanka
Europe
Spain
South Africa
Belgium
Hungary
Faroe Islands
Vietnam
Belarus
Bahrain
Gibraltar
France
Japan
Barbados
Greece
Belize
Hong Kong
China
Algeria
Ghana
Singapore
Denmark
Finland
Estonia
Croatia
Bermuda
Middle East
Chile
Costa Rica
Georgia
Ecuador
Bulgaria
LATAM
Czech Republic
Ethiopia
Egypt
Africa
Liberia
Kuwait
Philippines
Malaysia
Morocco
Peru
Nicaragua
Malta
Liechtenstein
Mexico
Lithuania
Oceania
Lebanon
Jersey
Myanmar
Mali
Israel
Panama
Italy
Mauritius
Norway
Ukraine
Turkey
Serbia
Sierra Leone
Rwanda
Venezuela
Sweden
Indonesia
Senegal
Tajikistan
Puerto Rico
Portugal
Slovenia
Dominican Republic
Uganda
Bahamas
Taiwan
Togo
Russian Federation
Tanzania
Zimbabwe
San Marino
Namibia
Uruguay
Azerbaijan
Iceland
Poland
El Salvador
Thailand
Nigeria
Tunisia
Zambia
Uzbekistan
Iraq
United Arab Emirates
Jamaica
Mozambique
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Kenya
Grenada
Jordan
Romania
Argentina
Bangladesh
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Colombia
Austria
Cameroon
Switzerland
Guatemala
Seychelles
Marshall Islands
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 5 Biotechnology Angel Investors in Australia in May 2026

A list of 5 angel investors that invest in Biotechnology startups based in Australia. We rank investors based on the number of investments they made in Biotechnology companies from Australia. We update this investor list every month.

Top 5 Biotechnology Angel Investors in Australia in May 2026

Investor Biotechnology Australia investments
Mike Wallas 2
Allan Moss 2
Benny Kleist 1
Artesian Investment 1
Catherine Lacavera 1

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
Mike Wallas
Angel · Brisbane, Queensland, Australia

Mike Wallas - Advisory Board @ Optifire Pty Ltd

Show more...

Investment focus

  • Video, Water, Biotechnology
  • Seed, Funding Round
  • Australia

Portfolio highlights

  • PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
  • Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Show all investments...

Allan Moss
Angel · Sydney, New South Wales, Australia

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Show all investments...

Benny Kleist
Angel · Sydney, New South Wales, Australia

Benny Kleist is a Founder & COO of Eucalyptus.He attended The University of Queensland.

Show more...

Investment focus

  • Education, E-Learning, Life Science
  • Pre-Seed, Series A
  • Australia, New Zealand

Portfolio highlights

  • Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
  • NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
Show all investments...

Artesian Investment
Angel

Artesian Investment

Show more...

Investment focus

  • Artificial Intelligence, Agriculture, Information Technology
  • Pre-Seed, Seed, Series A
  • United States, India, Australia

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
  • LYRO Robotics — A robotic packing solution for fruits and vegetables
  • HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Show all investments...

Catherine Lacavera
Angel · San Francisco Bay Area, California, United States

Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Seed, Pre-Seed
  • Canada, Australia

Portfolio highlights

  • Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
Show all investments...
Investors by industry
Investors by country
Angel Investors in Australia by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!